<DOC>
	<DOCNO>NCT00885313</DOCNO>
	<brief_summary>The purpose interventional study evaluate efficacy tolerability docosahexaenoic acid ( DHA ) child adolescents well-characterized liver biopsy confirm nonalcoholic fatty liver disease ( NAFLD ) .</brief_summary>
	<brief_title>Effects Docosahexaenoic Acid ( DHA ) Children With Nonalcoholic Fatty Liver Disease ( NAFLD )</brief_title>
	<detailed_description>Sixty child adolescent ( 4-16 year ) liver biopsy proven NAFLD enrol . They randomize treatment DHA 250 mg/kg/d ( n=20 ) , DHA 500 mg/kg/d ( n=20 ) , identical placebo ( n=20 ) give orally period 24 month . All patient include lifestyle intervention program consist diet tailor individual requirement physical exercise . Patients undergo medical evaluation every three month 24-month study period . Liver biopsy perform baseline end treatment . Anthropometric analysis , laboratory test , include liver enzymes lipids repeat 3-month interval 24-month study duration . Ultrasonography Fibroscan liver repeat end study period .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>persistently elevate serum aminotransferase level diffusely echogenic liver image study suggestive fatty liver biopsy consistent diagnosis NAFLD hepatic virus infection ( HCV RNAPCR negative ) Hepatitis A , B , C , D , E G cytomegalovirus EpsteinBarr virus alcohol consumption history parenteral nutrition use drug know induce steatosis affect body weight carbohydrate metabolism autoimmune liver disease , metabolic liver disease , Wilson 's disease , a1antitrypsinassociated liver disease rule use standard clinical , laboratory histological criterion</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>NAFLD</keyword>
	<keyword>NASH</keyword>
	<keyword>fibrosis</keyword>
</DOC>